These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


285 related items for PubMed ID: 2302145

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
    Umehara M, Ago Y, Kawanai T, Fujita K, Hiramatsu N, Takuma K, Matsuda T.
    Behav Pharmacol; 2013 Aug; 24(4):328-31. PubMed ID: 23751518
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.
    Soeters HS, Howells FM, Russell VA.
    Metab Brain Dis; 2008 Sep; 23(3):303-14. PubMed ID: 18665438
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].
    Ueno K, Togashi H, Yoshioka M.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):47-55. PubMed ID: 12690641
    [Abstract] [Full Text] [Related]

  • 9. The Effect of Methylphenidate on the Microstructure of Schedule-Induced Polydipsia in an animal model of ADHD.
    Íbias J, Daniels CW, Miguéns M, Pellón R, Sanabria F.
    Behav Brain Res; 2017 Aug 30; 333():211-217. PubMed ID: 28669538
    [Abstract] [Full Text] [Related]

  • 10. Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder--lack of effect of methylphenidate.
    Warton FL, Howells FM, Russell VA.
    Metab Brain Dis; 2009 Dec 30; 24(4):599-613. PubMed ID: 19821016
    [Abstract] [Full Text] [Related]

  • 11. Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder.
    Russell V, de Villiers A, Sagvolden T, Lamm M, Taljaard J.
    Behav Brain Res; 1998 Jul 30; 94(1):163-71. PubMed ID: 9708847
    [Abstract] [Full Text] [Related]

  • 12. Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
    Mc Fie S, Sterley TL, Howells FM, Russell VA.
    Brain Res; 2012 Jul 27; 1467():91-103. PubMed ID: 22658977
    [Abstract] [Full Text] [Related]

  • 13. Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder.
    Marusich JA, McCuddy WT, Beckmann JS, Gipson CD, Bardo MT.
    Behav Pharmacol; 2011 Dec 27; 22(8):794-804. PubMed ID: 22015805
    [Abstract] [Full Text] [Related]

  • 14. Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder.
    Ueno KI, Togashi H, Mori K, Matsumoto M, Ohashi S, Hoshino A, Fujita T, Saito H, Minami M, Yoshioka M.
    Behav Pharmacol; 2002 Feb 27; 13(1):1-13. PubMed ID: 11990715
    [Abstract] [Full Text] [Related]

  • 15. Individual differences in novelty-seeking behavior in spontaneously hypertensive rats: Enhanced sensitivity to the reinforcing effect of methylphenidate in the high novelty-preferring subpopulation.
    dela Peña I, Gonzales EL, de la Peña JB, Kim BN, Han DH, Shin CY, Cheong JH.
    J Neurosci Methods; 2015 Aug 30; 252():48-54. PubMed ID: 25169048
    [Abstract] [Full Text] [Related]

  • 16. Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments.
    Jordan CJ, Harvey RC, Baskin BB, Dwoskin LP, Kantak KM.
    Drug Alcohol Depend; 2014 Jul 01; 140():25-32. PubMed ID: 24811203
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.